Borenstein J - Search Results

1

The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy.

Rodby RA, Chiou CF, Borenstein J, Smitten A, Sengupta N, Palmer AJ, Roze S, Annemans L, Simon TA, Chen RS, Lewis EJ; Collaborative Study Group. Rodby RA, et al. Among authors: borenstein j. Clin Ther. 2003 Jul;25(7):2102-19. doi: 10.1016/s0149-2918(03)80208-4. Clin Ther. 2003. PMID: 12946554

2

Validation of a rheumatoid arthritis health-related quality of life instrument, the CSHQ-RA.

Russak SM, Sherbourne CD, Lubeck DP, Paulus HD, Chiou CF, Sengupta N, Borenstein J, Ofman J, Moadel A, Weisman MH. Russak SM, et al. Among authors: borenstein j. Arthritis Rheum. 2003 Dec 15;49(6):798-803. doi: 10.1002/art.11478. Arthritis Rheum. 2003. PMID: 14673966 Free article.

3

Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception.

Blumenthal PD, Trussell J, Singh RH, Guo A, Borenstein J, Dubois RW, Liu Z. Blumenthal PD, et al. Among authors: borenstein j. Contraception. 2006 Sep;74(3):249-58. doi: 10.1016/j.contraception.2006.03.024. Epub 2006 May 23. Contraception. 2006. PMID: 16904420 Review.

4

Development of a new instrument for rheumatoid arthritis: the Cedars-Sinai Health-Related Quality of Life instrument (CSHQ-RA).

Weisman MH, Paulus HE, Russak SM, Lubeck DP, Chiou CF, Sengupta N, Ofman JJ, Borenstein J, Moadel AB, Sherbourne CD. Weisman MH, et al. Among authors: borenstein j. Arthritis Rheum. 2003 Feb 15;49(1):78-84. doi: 10.1002/art.10915. Arthritis Rheum. 2003. PMID: 12579597 Free article.

5

Differences in symptom scores and health outcomes in premenstrual syndrome.

Borenstein JE, Dean BB, Leifke E, Korner P, Yonkers KA. Borenstein JE, et al. J Womens Health (Larchmt). 2007 Oct;16(8):1139-44. doi: 10.1089/jwh.2006.0230. J Womens Health (Larchmt). 2007. PMID: 17937566

6

Evaluating the criteria used for identification of PMS.

Dean BB, Borenstein JE, Knight K, Yonkers K. Dean BB, et al. J Womens Health (Larchmt). 2006 Jun;15(5):546-55. doi: 10.1089/jwh.2006.15.546. J Womens Health (Larchmt). 2006. PMID: 16796482

7

Economic analysis of contraceptives for women.

Chiou CF, Trussell J, Reyes E, Knight K, Wallace J, Udani J, Oda K, Borenstein J. Chiou CF, et al. Among authors: borenstein j. Contraception. 2003 Jul;68(1):3-10. doi: 10.1016/s0010-7824(03)00078-7. Contraception. 2003. PMID: 12878280

8

Physician attitudes toward strategies to promote the adoption of medical evidence into clinical practice.

Borenstein J, Chiou CF, Henning JM, Wilson A, Hohlbauch AA, Richards MS, Ofman JJ, Weingarten SR. Borenstein J, et al. Am J Manag Care. 2003 Mar;9(3):225-34. Am J Manag Care. 2003. PMID: 12643340 Free article.

9

Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life.

Borenstein J, Yu HT, Wade S, Chiou CF, Rapkin A. Borenstein J, et al. J Reprod Med. 2003 Feb;48(2):79-85. J Reprod Med. 2003. PMID: 12621790

10

Estimating direct and indirect costs of premenstrual syndrome.

Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Borenstein J, et al. J Occup Environ Med. 2005 Jan;47(1):26-33. doi: 10.1097/01.jom.0000150209.44312.d1. J Occup Environ Med. 2005. PMID: 15643156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters